Latest On Milestone Pharmaceuticals Inc (MIST):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-23 00:11 EST | News | Milestone Pharmaceuticals: Worthy Of A Dart Throw | N/A |  |
| 2023-05-11 22:11 EST | News | Milestone Pharmaceuticals GAAP EPS of -$0.35 beats by $0.05, revenue of $1M | N/A | |
| 2023-03-30 06:39 EST | News | Milestone Pharmaceuticals GAAP EPS of -$0.31, revenue of $3.5M | N/A | |
| 2023-03-29 00:27 EST | News | Milestone Pharma receives $125M financing to support etripamil development | N/A | |
| 2022-11-10 19:58 EST | News | Milestone Pharmaceuticals GAAP EPS of -$0.34 beats by $0.07, revenue of $1.5M | N/A | |
About Milestone Pharmaceuticals Inc (MIST):
Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for the treatment of atrial fibrillation, angina, and other cardiovascular indications. The company was founded in 2003 and is headquartered in Montréal, Canada.
General
- Name Milestone Pharmaceuticals Inc
- Symbol MIST
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 28
- Fiscal Year EndDecember
- IPO Date2019-05-09
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Web URLhttp://www.milestonepharma.com
Valuation
- Price/Book (Most Recent Quarter) 2.1
- Enterprise Value EBITDA 0.3
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.52
- Return on Assets -30%
- Return on Equity -51%
- Earnings Per Share -$10.84
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 218.01 million
- EBITDA -41145000
- PE Ratio -1.27
- Analyst Target Price $14.6
- Book Value Per Share $4.13
Share Statistics
- Shares Outstanding 29.82 million
- Shares Float 11.04 million
- % Held by Insiders 956%
- % Held by Institutions 70.1%
- Shares Short 252880
- Shares Short Prior Month 236294
- Short Ratio 2.23
- Short % of Float 1%
- Short % of Shares Outstanding 1%
Technicals
- 52 Week High $16.98
- 52 Week Low $1.69
- 50 Day Moving Average 7.66
- 200 Day Moving Average 7.19
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Milestone Pharmaceuticals Inc (MIST) Dividend Calendar:
Milestone Pharmaceuticals Inc (MIST) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Milestone Pharmaceuticals Inc (MIST) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Milestone Pharmaceuticals Inc (MIST) Chart:
Milestone Pharmaceuticals Inc (MIST) News:
Below you will find a list of latest news for Milestone Pharmaceuticals Inc (MIST) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Milestone Pharmaceuticals Inc (MIST) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest MIST Trades:
Milestone Pharmaceuticals Inc (MIST) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-10-29 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-26 | 424B5 (Prospectus [Rule 424(b)(5)]) | |
| 2020-10-26 | 8-K (Current report) | |
| 2020-10-23 | 10-K/A (Annual report [Section 13 and 15(d), not S-K Item 405]) | |
| 2020-10-22 | 424B5 (Prospectus [Rule 424(b)(5)]) | |
| 2020-10-22 | S-3MEF (Registration adding securities to prior Form S-3 registration [Rule 462(b)]) | |
| 2020-10-05 | 3 (Initial statement of beneficial ownership of securities) | |
| 2020-10-05 | 3 (Initial statement of beneficial ownership of securities) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-22 | 8-K (Current report) | |
| 2020-08-28 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-20 | S-3 (Registration statement under Securities Act of 1933) | |
| 2020-08-12 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-08-03 | SC 13G (Statement of acquisition of beneficial ownership by individuals) | |
| 2020-07-30 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-29 | 424B5 (Prospectus [Rule 424(b)(5)]) | |
| 2020-07-29 | 8-K (Current report) | |
| 2020-07-24 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-23 | 8-K (Current report) | |
Milestone Pharmaceuticals Inc (MIST) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Milestone Pharmaceuticals Inc (MIST). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 956%
Institutional Ownership: 7010%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-08-26 | Lorenz Muller | Chief Commercial Officer | Buy | 5,700.00 | 1.54 | 8,778.00 | 108,386.00 | |
| 2020-07-29 | DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC FONDS | 10% Share Holder | Sell | 500,000.00 | 8.32 | 4,160,000.00 | 2,254,920.00 | |
| 2020-07-28 | DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC FONDS | 10% Share Holder | Sell | 19,863.00 | 8.10 | 160,890.30 | 2,754,920.00 | |
| 2020-04-03 | Lorenz Muller | Chief Commercial Officer | Buy | 18,043.00 | 1.54 | 27,786.22 | 102,686.00 | |
| 2020-04-03 | Lorenz Muller | Chief Commercial Officer | Buy | 32,528.00 | 1.54 | 50,093.12 | 84,643.00 | |
| 2020-03-19 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 5,870.00 | 10.87 | 63,803.97 | 4,315,102.00 | |
| 2020-03-18 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 2,705.00 | 10.36 | 28,028.67 | 4,309,232.00 | |
| 2020-03-02 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 78,263.00 | 18.95 | 1,483,083.85 | 4,306,527.00 | |
| 2020-01-13 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 270,000.00 | 16.25 | 4,387,500.00 | 4,228,264.00 | |
| 2019-12-31 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 21,438.00 | 15.50 | 332,340.45 | 3,958,264.00 | |
| 2019-12-30 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 1,333.00 | 15.48 | 20,637.77 | 3,936,826.00 | |
| 2019-12-21 | Joseph Oliveto | President and CEO | Buy | 7,400.00 | 1.54 | 11,396.00 | 280,555.00 | |
| 2019-11-25 | Holdings A/S Novo | 10% Share Holder | Sell | 240,000.00 | 16.00 | 3,840,000.00 | 2,434,470.00 | |
| 2019-11-20 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 400,000.00 | 16.00 | 6,400,000.00 | 3,935,493.00 | |
| 2019-10-15 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 1,100.00 | 18.00 | 19,800.00 | 3,535,493.00 | |
| 2019-10-11 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 4,208.00 | 17.30 | 72,790.83 | 3,534,393.00 | |
| 2019-10-10 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 179.00 | 16.00 | 2,864.00 | 3,530,185.00 | |
| 2019-10-03 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 1,908.00 | 18.31 | 34,939.87 | 3,530,006.00 | |
| 2019-10-01 | RTW INVESTMENTS, LP | 10% Share Holder | Buy | 6,242.00 | 17.63 | 110,038.97 | 3,528,098.00 | |
| 2019-10-01 | Lorenz Muller | Chief Commercial Officer | Buy | 2,500.00 | 1.54 | 3,850.00 | 52,115.00 | |